Get the Stockscreener App
0.00
100.00%
-79.97
After Hours:
79.98
79.98
+
Inari Medical Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from Chronic Venous Disease. Its product portfolio includes; ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTriever System product is used for the treatment of pulmonary embolism, InThrill system to treat small vessel thrombosis, LimFlow system and others. Geographically, the company generates majority of its revenue from United States and rest from International markets.
See More
Previous Close:
$79.97
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$4.67B
Revenue:
$574.50M
Net Income/Loss:
$-78.58M
P/E Ratio:
0.00
EPS:
-1.35
Net Cash Flow:
$1.58M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$79.99
Inari Medical Inc Stock (NARI) Company Profile
Name
Inari Medical Inc
Sector
Industry
Phone
949-923-4747
Address
6001 OAK CANYON, SUITE 100, IRVINE, CA
Compare NARI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NARI
Inari Medical Inc
|
0.00 | 4.67B | 574.50M | -78.58M | 1.58M | -1.35 |
|
ABT
Abbott Laboratories
|
134.80 | 231.82B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
106.04 | 152.18B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
394.21 | 145.57B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
86.44 | 107.07B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
78.00 | 43.22B | 5.54B | 4.18B | 623.10M | 7.00 |
Inari Medical Inc Stock (NARI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-17-24 | Initiated | Oppenheimer | Outperform |
| Sep-18-24 | Initiated | Stifel | Hold |
| Sep-03-24 | Initiated | Leerink Partners | Market Perform |
| Aug-09-24 | Initiated | Deutsche Bank | Buy |
| Jul-25-24 | Initiated | William Blair | Outperform |
| Jul-18-24 | Downgrade | Needham | Buy → Hold |
| Feb-29-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-23-24 | Initiated | Needham | Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Sep-29-22 | Initiated | Berenberg | Buy |
| Sep-13-22 | Initiated | Truist | Hold |
| Jun-21-22 | Initiated | Piper Sandler | Overweight |
| Mar-23-22 | Resumed | BofA Securities | Buy |
| Dec-15-20 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Nov-18-20 | Initiated | BTIG Research | Buy |
| Oct-29-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-28-20 | Initiated | SVB Leerink | Outperform |
| Jun-19-20 | Initiated | Canaccord Genuity | Buy |
| Jun-16-20 | Initiated | BofA/Merrill | Neutral |
| Jun-16-20 | Initiated | Morgan Stanley | Equal-Weight |
| Jun-16-20 | Initiated | Wells Fargo | Equal Weight |
View All
Inari Medical Inc Stock (NARI) Latest News
Inari Medical, Inc. (NARI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Levi & Korsinsky Reminds Inari Medical Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 12, 2024NARI - ACCESS Newswire
Did Inari Medical, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky InvestigateNARI - ACCESS Newswire
Shareholders that lost money on Inari Medical, Inc.(NARI) should contact Levi & Korsinsky about pending Class ActionNARI - ACCESS Newswire
Lost Money on Inari Medical, Inc.(NARI)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire
Investors who lost money on Inari Medical, Inc.(NARI) should contact Levi & Korsinsky about pending Class ActionNARI - ACCESS Newswire
Press Release Distribution & PR Platform - ACCESS Newswire
Lost Money on Inari Medical, Inc.(NARI)? Contact Levi & Korsinsky Regarding an Ongoing Investigation - ACCESS Newswire
Inari Medical, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – NARI - ACCESS Newswire
Inari Medical, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More InformationNARI - ACCESS Newswire
Shareholders of Inari Medical, Inc. Should Contact Levi & Korsinsky Before July 12, 2024 to Discuss Your RightsNARI - ACCESS Newswire
Class Action Filed Against Inari Medical, Inc. (NARI) Seeking Recovery for InvestorsContact Levi & Korsinsky - ACCESS Newswire
An Investigation Has Commenced on Behalf of Inari Medical, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your NARI Losses - ACCESS Newswire
Inari Medical, Inc. (NARI) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky, LLP Investigates - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Inari Medical, Inc. (NARI) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Inari Medical Inc Stock (NARI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.85%
0.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):